查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1224511

基因合成市場規模、份額和趨勢分析:方法(固相合成、芯片合成、PCR基底□合成)、服務、應用、用途、地區、市場、2023-2030年

Gene Synthesis Market Size, Share & Trends Analysis Report By Method (Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis), By Service, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 176 Pages | 商品交期: 2-10個工作天內

價格

基因合成市場的增長和趨勢

Grand View Research, Inc. 的最新報告預測，2023 年至 2030 年全球基因合成市場規模將以 16.1% 的複合年增長率增長，到 2030 年將達到 57.8 億美元。 市場的發展是由於合成生物學領域投資的增加、有利的政府法規以及基因合成市場的技術進步。 2022 年 1 月，合成 DNA 製造商 Twisted Biosciences 在 J.P. Morgan Healthcare Conference 上宣布了開發 EDS 技術的計劃。 公司建立了一種新穎、低成本、無疤痕、高度可擴展的□促 DNA 合成技術。

為了滿足研究人員日益增長的需求，引入具有技術先進規格的新 DNA 合成平台也促進了整體增長。 例如，2021年6月，DNAscript發布了基於EDS技術的核酸打印機SYNTAX System。 同樣，2020 年 12 月，Evonetics, Inc. 與 Analog Devices, Inc. 進行了研究合作。 根據協議，兩家公司將在 Evonetix 基於微機電系統的矽芯片的改進和商業化以及 DNA 桌面寫入器的開發方面進行合作。

近年來，不僅是研究人員，生物技術和製藥公司也對靶向治療產生了更大的興趣。 近年來，研究人員、生物技術公司和製藥公司對靶向治療的興趣越來越大，它們作為疾病管理的工具越來越受到關注。 在不久的將來，靶向療法結合化學療法和免疫療法具有顯著發展的潛力，為基因合成市場的新興和老牌競爭者提供了良好的前景。

主要參與者專注於產品開發並建立合作夥伴關係和協作以擴展其產品範圍。 例如，2022 年 1 月，Thermo Fisher Scientific 完成了對抗體和載體生產商 PeproTech, Inc. 的收購。 此次收購可以幫助公司鞏固其市場地位。 同樣，2021 年 7 月，金斯瑞舉辦了金斯瑞基因與細胞工程虛擬峰會。 該活動將使公司能夠擴大其客戶群，重點關注合成生物學研究，以增強蛋白質設計、藥物發現和基因組編輯。

基因合成市場報告亮點

對合成生物學的需求不斷增長以及政府對合成生物學研究和開發的資金支持不斷增加是推動該市場增長的因素

在方法方面，固相合成在 2022 年佔據主導地位，因為它具有高精度，是一種適用於各個領域和各種研究目的的強大技術

按服務劃分，抗體 DNA 合成在 2022 年主導了基因合成市場。 這是由於重要參與者的存在，如 Synbio 提供服務、Twist Bioscience Corporation 等，它們在這一領域提供服務。

按應用劃分，基因和細胞療法開發領域在 2022 年主導了基因合成市場。 這是由於越來越多的細胞和基因治療開發研究和開發計劃

就最終用途而言，學術和政府研究機構將在 2022 年主導基因合成市場，因為大部分基因合成過程將在臨床研究和試驗項目的研究環境中進行

p>

由於其完善的分子生物學基礎設施和該地區眾多市場參與者的存在，北美將在 2022 年佔據最高份額。

目次

第 1 章基因合成市場：研究方法和範圍

  • 市場細分
    • 細分範圍
    • 區域範圍
  • 調查方法
  • 資訊採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要資訊
    • 初步調查
    • 初步調查的詳細資訊
  • 資訊或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細資訊
    • 商品流分析
      • 方法 1：商品流方法
      • 方法 2：使用自下而上的方法按國家/地區進行市場預測
      • 方法 3：使用自上而下的方法逐個國家/地區進行市場估算
  • 全球市場：CAGR 計算
  • 區域市場：CAGR 計算
  • 次要資訊列表
  • 目的
  • 縮寫列表

第 2 章基因合成市場：執行摘要

  • 基因合成市場：市場展望
    • 市場概覽

第 3 章基因合成市場：行業展望

  • 市場系列展望
    • 母市場沿襲預測
    • 相關/子公司市場前景
  • 描繪滲透率和增長前景
  • 市場動態
    • 市場促進因素
      • 增加對合成生物學市場的投資
      • □促 DNA 合成過程的出現
      • DNA 合成平台的技術進步
      • DNA 合成和測序的價格下降
    • 市場抑制因素分析
      • 缺乏熟練的專業人員
      • 濫用基因合成
  • SWOT 分析，按因素（政治和法律、經濟和技術）
  • 行業分析 - 波特五力分析
  • 報銷和監管場景
  • 主要交易和戰略聯盟
    • 新產品發布
    • 取得
    • 分機
    • 夥伴關係
    • 營銷和推廣

第 4 章基因合成市場：競爭格局

  • 主要市場進入者的近期發展和影響分析
    • Ansoff Matrix
  • 公司分類
    • 創新者
      • 市場差異化因素
  • 供應商概況
    • 主要分銷商和渠道合作夥伴列表
    • 主要客戶
    • 2022 年主要參與者的市場份額分析
  • 上市公司
    • 競爭儀錶盤分析
  • 私人公司
    • 主要初創企業名單
  • 本地網絡地圖

第 5 章基因合成市場：方法業務分析

  • 基因合成市場：方法變異分析
  • 固相合成
  • 基於芯片的合成
  • 基於 PCR 的□促合成

第 6 章基因合成市場：服務業務分析

  • 基因合成市場：服務波動分析
  • 抗體DNA合成
  • 病毒DNA合成
  • 其他

第 7 章基因合成市場：應用業務分析

  • 基因合成市場：應用的變化分析
  • 基因和細胞療法的發展
  • 疫苗開發
  • 疾病診斷
  • 其他

第 8 章基因合成市場：最終用途業務分析

  • 基因合成市場：最終用途變異分析
  • 生物技術和製藥公司
  • 學術研究機構和政府研究機構
  • 委託研究機構

第 9 章基因合成市場：區域業務分析

  • 北美
    • SWOT 分析
    • 美國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 加拿大
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
  • 歐洲
    • SWOT 分析：
    • 德國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 英國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 法國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 意大利
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 西班牙
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 丹麥
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 瑞典
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 挪威
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
  • 亞太地區
    • SWOT 分析：
      • 主要區域動態
    • 日本
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 中國
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 印度
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 韓國
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 澳大利亞
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 泰國
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
  • 拉丁美洲
    • SWOT 分析：
    • 主要地區動態
    • 巴西
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 墨西哥
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 阿根廷
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
  • 中東和非洲 (MEA)
    • SWOT 分析：
    • 主要地區動態
    • 南非
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 沙特阿拉伯
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 阿拉伯聯合酋長國
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 科威特
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景

第 10 章基因合成市場：公司概況

  • 公司簡介
    • GenScript
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Brooks Automation, Inc. (GENEWIZ)
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Boster Biological Technology
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Twist Bioscience
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • ProteoGenix, Inc.
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Biomatik
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • ProMab Biotechnologies, Inc.
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Thermo Fisher Scientific, Inc.
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Integrated DNA Technologies, Inc.
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
    • OriGene Technologies, Inc.
      • 公司概況
      • 財務業績
      • 產品基準
      • 戰略舉措
  • 其他主要參與者名單
Product Code: GVR-4-68039-597-3

Gene Synthesis Market Growth & Trends:

The global gene synthesis market size is expected to reach USD 5.78 billion by 2030, registering a CAGR of 16.1% from 2023 to 2030 according to a new report by Grand View Research, Inc. Development of the market is due to the growing investment in the synthetic biology field, favorable government regulations, and technological advancements in the gene synthesis market. In January 2022, synthetic DNA manufacturer Twist Bioscience announced plans of developing EDS technology at the J.P. Morgan Health Care Conference. The company established an enzymatic DNA synthesis technology that is novel, low-cost, scarless, and scalable.

The introduction of novel DNA synthesis platforms with technologically advanced specifications that address the increased demand of researchers is also contributing to the overall growth. For instance, in June 2021, DNA Script introduced the SYNTAX System, which is the nucleic acid printer based on EDS technology. Similarly, in December 2020, Evonetix Ltd. entered into a research collaboration with Analog Devices, Inc. Under the terms of the agreement, the companies collaborated on Evonetix's Microelectromechanical System-based silicon chips' improvement and commercial scale-up, as well as the development of a DNA desktop writer.

Researchers, as well as biotechnology and pharmaceutical corporations, have become increasingly interested in targeted therapy during recent years. It has become a popular method of disease management. In the near future, targeted therapy in conjunction with chemotherapy and immunotherapy is likely to develop significantly, presenting lucrative prospects for both emerging & established competitors in the gene synthesis market.

Key players are focusing on product development and are entering into partnerships and collaborations to expand their product offerings. For instance, In January 2022, Thermo Fisher Scientific, Inc. completed the acquisition of PeproTech, Inc.- a producer of antibodies and vectors. This acquisition may help the company strengthen its position in the market. Similarly, in July 2021, GenScript hosted the GenScript Gene & Cell Engineering Virtual Summit. This event focused on highlighting synthetic biology research to enhance protein design, drug discovery, and genome editing, enabling the company to increase its customer base.

Gene Synthesis Market Report Highlights:

  • The growth is attributed to the growing demand for the synthetic biology, coupled with increasing government support to offer funds for R&D initiatives in synthetic biology
  • By method, solid-phase synthesis dominated in 2022 as it offers high accuracy and is a prominent technology for the applications in several fields and for various research purposes
  • By services, antibody DNA synthesis dominated the gene synthesis market in 2022, owing to the presence of significant players such as Synbio offers services, Twist Bioscience Corporation, and others, offering services in this segment
  • By application, the gene & cell therapy development segment dominated the gene synthesis market in 2022. This is attributed to the growing number of R&D programs for the development of cell and gene therapies
  • By end-use, academic and government research institute dominated the gene synthesis market in 2022, as most of the gene synthesis process is performed in the research settings for clinical research and investigational programs
  • North America captured the highest share in 2022 owing to the well-established molecular biology infrastructure along with the presence of a significant number of market players in the region

Table of Contents

Chapter 1 Gene Synthesis Market: Methodology And Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
      • 1.6.1.3 Approach 2: Country Wise Market Estimation Using Top Down Approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Regional Market: CAGR Calculation
  • 1.9 List Of Secondary Sources
  • 1.10 Objectives
    • 1.10.1 Objective 1:
    • 1.10.2 Objective 2:
  • 1.11 List of Abbreviations

Chapter 2 Gene Synthesis Market: Executive Summary

  • 2.1 Gene Synthesis Market: Market Outlook
    • 2.1.1 Market Summary

Chapter 3 Gene Synthesis Market: Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 Rising investment in synthetic biology market
      • 3.3.1.2 Advent of enzymatic DNA synthesis process
      • 3.3.1.3 Technological advancements in the DNA synthesis platforms
      • 3.3.1.4 Declining price of DNA synthesis & sequencing
    • 3.3.2 Market restraint Analysis
      • 3.3.2.1 Lack of skilled professionals
      • 3.3.2.2 Misuse of gene synthesis
  • 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Reimbursement & Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships
    • 3.7.5 Marketing & Promotions

Chapter 4 Gene Synthesis Market: Competitive Landscape

  • 4.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 4.1.1 Ansoff Matrix
  • 4.2 Company Categorization
    • 4.2.1 Innovators
      • 4.2.1.1 Market Differentiators
  • 4.3 Vendor Landscape
    • 4.3.1 List Of Key Distributors And Channel Partners
    • 4.3.2 Key Customers
    • 4.3.3 Key Company Market Share Analysis, 2022
  • 4.4 Public Companies
    • 4.4.1 Competitive Dashboard Analysis
  • 4.5 Private Companies
    • 4.5.1 List Of Key Emerging Companies
  • 4.6 Regional Network Map

Chapter 5 Gene Synthesis Market: Method Business Analysis

  • 5.1 Gene Synthesis Market: Method Movement Analysis
  • 5.2 Solid-phase Synthesis
    • 5.2.1 Solid-phase Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.3 Chip-based Synthesis
    • 5.3.1 Chip-based Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.4 PCR-based Enzyme Synthesis
    • 5.4.1 PCR-based Enzyme Synthesis market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Gene Synthesis Market: Services Business Analysis

  • 6.1 Gene Synthesis Market: Services Movement Analysis
  • 6.2 Antibody DNA Synthesis
    • 6.2.1 Antibody DNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3 Viral DNA Synthesis
    • 6.3.1 Viral DNA Synthesis market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4 Others
    • 6.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Gene Synthesis Market: Application Business Analysis

  • 7.1 Gene Synthesis Market: Application Movement Analysis
  • 7.2 Gene & Cell Therapy Development
    • 7.2.1 Gene & Cell Therapy Development market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3 Vaccine Development
    • 7.3.1 Vaccine Development market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4 Disease Diagnosis
    • 7.4.1 Disease Diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5 Others
    • 7.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Gene Synthesis Market: End-use Business Analysis

  • 8.1 Gene Synthesis Market: End-use Movement Analysis
  • 8.2 Biotechnology and Pharmaceutical Companies
    • 8.2.1 Biotechnology and Pharmaceutical Companies market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.3 Academic and Government Research Institutes
    • 8.3.1 Academic And Government Research Institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4 Contract Research Organizations
    • 8.4.1 Contract Research Organizations market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Gene Synthesis Market: Regional Business Analysis

  • 9.1 North America
    • 9.1.1 Swot Analysis
      • 9.1.1.1 North America Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.1.2 U.S.
      • 9.1.2.1 Key Country Dynamics
      • 9.1.2.2 Target Disease Prevalence
      • 9.1.2.3 Competitive Scenario
      • 9.1.2.4 Regulatory Framework
      • 9.1.2.5 Reimbursement Scenario
      • 9.1.2.6 U.S. Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.1.3 CANADA
      • 9.1.3.1 Key Country Dynamics
      • 9.1.3.2 Target Disease Prevalence
      • 9.1.3.3 Competitive Scenario
      • 9.1.3.4 Regulatory Framework
      • 9.1.3.5 Reimbursement Scenario
      • 9.1.3.6 Canada Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.2 Europe
    • 9.2.1 SWOT Analysis:
      • 9.2.1.1 Europe Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2 Germany
      • 9.2.2.1 Key Country Dynamics
      • 9.2.2.2 Target Disease Prevalence
      • 9.2.2.3 Competitive Scenario
      • 9.2.2.4 Regulatory Framework
      • 9.2.2.5 Reimbursement Scenario
      • 9.2.2.6 Germany Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.3 UK
      • 9.2.3.1 Key Country Dynamics
      • 9.2.3.2 Target Disease Prevalence
      • 9.2.3.3 Competitive Scenario
      • 9.2.3.4 Regulatory Framework
      • 9.2.3.5 Reimbursement Scenario
      • 9.2.3.6 UK Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.4 FRANCE
      • 9.2.4.1 Key Country Dynamics
      • 9.2.4.2 Target Disease Prevalence
      • 9.2.4.3 Competitive Scenario
      • 9.2.4.4 Regulatory Framework
      • 9.2.4.5 Reimbursement Scenario
      • 9.2.4.6 France Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.5 Italy
      • 9.2.5.1 Key Country Dynamics
      • 9.2.5.2 Target Disease Prevalence
      • 9.2.5.3 Competitive Scenario
      • 9.2.5.4 Regulatory Framework
      • 9.2.5.5 Reimbursement Scenario
      • 9.2.5.6 Italy Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.6 Spain
      • 9.2.6.1 Key Country Dynamics
      • 9.2.6.2 Target Disease Prevalence
      • 9.2.6.3 Competitive Scenario
      • 9.2.6.4 Regulatory Framework
      • 9.2.6.5 Reimbursement Scenario
      • 9.2.6.6 Spain Cell & Gene Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.7 Denmark
      • 9.2.7.1 Key Country Dynamics
      • 9.2.7.2 Target Disease Prevalence
      • 9.2.7.3 Competitive Scenario
      • 9.2.7.4 Regulatory Framework
      • 9.2.7.5 Reimbursement Scenario
      • 9.2.7.6 Denmark Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.8 Sweden
      • 9.2.8.1 Key Country Dynamics
      • 9.2.8.2 Target Disease Prevalence
      • 9.2.8.3 Competitive Scenario
      • 9.2.8.4 Regulatory Framework
      • 9.2.8.5 Reimbursement Scenario
      • 9.2.8.6 Sweden Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.9 Norway
      • 9.2.9.1 Key Country Dynamics
      • 9.2.9.2 Target Disease Prevalence
      • 9.2.9.3 Competitive Scenario
      • 9.2.9.4 Regulatory Framework
      • 9.2.9.5 Reimbursement Scenario
      • 9.2.9.6 Norway Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3 Asia Pacific
    • 9.3.1 Swot Analysi:
      • 9.3.1.1 Key Region Dynamics
      • 9.3.1.2 Asia Pacific Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2 Japan
      • 9.3.2.1 Target Disease Prevalence
      • 9.3.2.2 Competitive Scenario
      • 9.3.2.3 Regulatory Framework
      • 9.3.2.4 Reimbursement Scenario
      • 9.3.2.5 Japan Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3 China
      • 9.3.3.1 Target Disease Prevalence
      • 9.3.3.2 Competitive Scenario
      • 9.3.3.3 Regulatory Framework
      • 9.3.3.4 Reimbursement Scenario
      • 9.3.3.5 China Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4 India
      • 9.3.4.1 Target Disease Prevalence
      • 9.3.4.2 Competitive Scenario
      • 9.3.4.3 Regulatory Framework
      • 9.3.4.4 Reimbursement Scenario
      • 9.3.4.5 India Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.5 South Korea
      • 9.3.5.1 Target Disease Prevalence
      • 9.3.5.2 Competitive Scenario
      • 9.3.5.3 Regulatory Framework
      • 9.3.5.4 Reimbursement Scenario
      • 9.3.5.5 South Korea Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.6 Australia
      • 9.3.6.1 Target Disease Prevalence
      • 9.3.6.2 Competitive Scenario
      • 9.3.6.3 Regulatory Framework
      • 9.3.6.4 Reimbursement Scenario
      • 9.3.6.5 Australia Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.7 Thailand
      • 9.3.7.1 Target Disease Prevalence
      • 9.3.7.2 Competitive Scenario
      • 9.3.7.3 Regulatory Framework
      • 9.3.7.4 Reimbursement Scenario
      • 9.3.7.5 Thailand Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4 Latin America
    • 9.4.1 Swot Analysis:
    • 9.4.2 Key Regional Dynamics
      • 9.4.2.1 Latin America Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3 Brazil
      • 9.4.3.1 Target Disease Prevalence
      • 9.4.3.2 Competitive Scenario
      • 9.4.3.3 Regulatory Framework
      • 9.4.3.4 Reimbursement Scenario
      • 9.4.3.5 Brazil Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4 Mexico
      • 9.4.4.1 Target Disease Prevalence
      • 9.4.4.2 Competitive Scenario
      • 9.4.4.3 Regulatory Framework
      • 9.4.4.4 Reimbursement Scenario
      • 9.4.4.5 Mexico Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5 Argentina
      • 9.4.5.1 Target Disease Prevalence
      • 9.4.5.2 Competitive Scenario
      • 9.4.5.3 Regulatory Framework
      • 9.4.5.4 Reimbursement Scenario
      • 9.4.5.5 Argentina Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5 Middle East & Africa (MEA)
    • 9.5.1 SWOT ANALYSIS:
    • 9.5.2 KEY regional DYNAMICS
      • 9.5.2.1 Middle East & Africa Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3 SOUTH AFRICA
      • 9.5.3.1 Target Disease Prevalence
      • 9.5.3.2 Competitive Scenario
      • 9.5.3.3 Regulatory Framework
      • 9.5.3.4 Reimbursement Scenario
      • 9.5.3.5 south Africail Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4 Saudi Arabia
      • 9.5.4.1 Target Disease Prevalence
      • 9.5.4.2 Competitive Scenario
      • 9.5.4.3 Regulatory Framework
      • 9.5.4.4 Reimbursement Scenario
      • 9.5.4.5 Saudi Arabia Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5 UAE
      • 9.5.5.1 Target Disease Prevalence
      • 9.5.5.2 Competitive Scenario
      • 9.5.5.3 Regulatory Framework
      • 9.5.5.4 Reimbursement Scenario
      • 9.5.5.5 UAE Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.6 Kuwait
      • 9.5.6.1 Target Disease Prevalence
      • 9.5.6.2 Competitive Scenario
      • 9.5.6.3 Regulatory Framework
      • 9.5.6.4 Reimbursement Scenario
      • 9.5.6.5 Kuwait Cell & Gene Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10 Gene Synthesis Market: Company Profiling

  • 10.1 Company Profiles
    • 10.1.1 GenScript
      • 10.1.1.1 Company overview
      • 10.1.1.2 Financial performance
      • 10.1.1.3 Product benchmarking
      • 10.1.1.4 Strategic initiatives
    • 10.1.2 Brooks Automation, Inc. (GENEWIZ)
      • 10.1.2.1 Company overview
      • 10.1.2.2 Financial performance
      • 10.1.2.3 Product benchmarking
      • 10.1.2.4 Strategic initiatives
    • 10.1.3 Boster Biological Technology
      • 10.1.3.1 Company overview
      • 10.1.3.2 Financial performance
      • 10.1.3.3 Product benchmarking
      • 10.1.3.4 Strategic initiatives
    • 10.1.4 Twist Bioscience
      • 10.1.4.1 Company overview
      • 10.1.4.2 Financial performance
      • 10.1.4.3 Product benchmarking
      • 10.1.4.4 Strategic initiatives
    • 10.1.5 ProteoGenix, Inc.
      • 10.1.5.1 Company overview
      • 10.1.5.2 Financial performance
      • 10.1.5.3 Product benchmarking
      • 10.1.5.4 Strategic initiatives
    • 10.1.6 Biomatik
      • 10.1.6.1 Company overview
      • 10.1.6.2 Financial performance
      • 10.1.6.3 Product benchmarking
      • 10.1.6.4 Strategic initiatives
    • 10.1.7 ProMab Biotechnologies, Inc.
      • 10.1.7.1 Company overview
      • 10.1.7.2 Financial performance
      • 10.1.7.3 Product benchmarking
      • 10.1.7.4 Strategic initiatives
    • 10.1.8 Thermo Fisher Scientific, Inc.
      • 10.1.8.1 Company overview
      • 10.1.8.2 Financial performance
      • 10.1.8.3 Product benchmarking
      • 10.1.8.4 Strategic initiatives
    • 10.1.9 Integrated DNA Technologies, Inc.
      • 10.1.9.1 Company overview
      • 10.1.9.2 Financial performance
      • 10.1.9.3 Product benchmarking
      • 10.1.9.4 Strategic initiatives
    • 10.1.10 OriGene Technologies, Inc.
      • 10.1.10.1 Company overview
      • 10.1.10.2 Financial performance
      • 10.1.10.3 Product benchmarking
      • 10.1.10.4 Strategic initiatives
  • 10.2 List of Other Key Players

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 4 Global Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 5 Global Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 7 Global Gene Synthesis Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 10 North America Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 11 North America Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 12 North America Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 14 U.S. Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 15 U.S. Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 16 U.S. Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 17 Canada Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 18 Canada Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 19 Canada Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 20 Canada Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 21 Europe Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 23 Europe Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 24 Europe Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 25 Europe Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 26 Germany Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 27 Germany Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 28 Germany Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 29 Germany Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 30 UK Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 31 UK Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 32 UK Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 33 UK Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 34 France Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 35 France Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 36 France Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 37 France Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 38 Italy Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 39 Italy Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 40 Italy Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 41 Italy Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 42 Spain Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 43 Spain Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 44 Spain Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 45 Spain Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 46 Denmark Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 47 Denmark Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 48 Denmark Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 49 Denmark Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 50 Sweden Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 51 Sweden Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 52 Sweden Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 53 Sweden Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 54 Norway Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 55 Norway Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 56 Norway Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 57 Norway Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 63 China Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 64 China Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 65 China Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 66 China Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 67 Japan Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 68 Japan Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 69 Japan Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 70 Japan Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 71 India Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 72 India Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 73 India Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 74 India Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 75 Australia Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 76 Australia Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 77 Australia Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 78 Australia Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 79 Thailand Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 80 Thailand Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 81 Thailand Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 82 Thailand Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 83 South Korea Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 84 South Korea Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 85 South Korea Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Korea Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 87 Latin America Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 89 Latin America Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 90 Latin America Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 91 Latin America Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 92 Brazil Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 93 Brazil Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 94 Brazil Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 95 Brazil Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 96 Mexico Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 97 Mexico Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 98 Mexico Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 99 Mexico Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 100 Argentina Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 101 Argentina Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 102 Argentina Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 103 Argentina Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Gene Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 109 South Africa Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 110 South Africa Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 111 South Africa Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 112 South Africa Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 117 UAE Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 118 UAE Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 119 UAE Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 120 UAE Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Gene Synthesis Market, by method, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Gene Synthesis Market, by services, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Gene Synthesis Market, by application, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Gene Synthesis Market, by end - use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain - Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Gene Synthesis, Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
  • Fig. 16 Global Gene Synthesis Market, : Method Movement Analysis
  • Fig. 17 Global Gene Synthesis Market, for Solid - phase Synthesis, 2018 - 2030 (USD Million)
  • Fig. 18 Global Gene Synthesis Market, for Chip - based Synthesis, 2018 - 2030 (USD Million)
  • Fig. 19 Global Gene Synthesis Market, for PCR - based Enzyme Synthesis, 2018 - 2030 (USD Million)
  • Fig. 20 Global Gene Synthesis Market, for Services, Movement Analysis
  • Fig. 21 Global Gene Synthesis Market, for Antibody DNA Synthesis, 2018 - 2030 (USD Million)
  • Fig. 22 Global Gene Synthesis Market, for Viral DNA Synthesis, 2018 - 2030 (USD Million)
  • Fig. 23 Global Gene Synthesis Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 24 Global Gene Synthesis Market, for Application, Movement Analysis
  • Fig. 25 Global Gene Synthesis Market, for Gene & Cell Therapy Development, 2018 - 2030 (USD Million)
  • Fig. 26 Global Gene Synthesis Market, for Vaccine Development, 2018 - 2030 (USD Million)
  • Fig. 27 Global Gene Synthesis Market, for Disease Diagnosis, 2018 - 2030 (USD Million)
  • Fig. 28 Global Gene Synthesis Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 29 Global Gene Synthesis Market, for End - use, Movement Analysis
  • Fig. 30 Global Gene Synthesis Market, for Biotechnology and pharmaceutical companies, 2018 - 2030 (USD Million)
  • Fig. 31 Global Gene Synthesis Market, for Academic and government research institutes, 2018 - 2030 (USD Million)
  • Fig. 32 Global Gene Synthesis Market, for Contract research organizations, 2018 - 2030 (USD Million)
  • Fig. 33 Regional Marketplace: Key Takeaways
  • Fig. 34 Regional Outlook, 2022 & 2030
  • Fig. 35 Global Gene Synthesis Market, : Region Movement Analysis
  • Fig. 36 North America Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 41 UK Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 42 France Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 50 China Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 51 India Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 52 Australia Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 59 Middle East and Africa Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait Gene Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 64 Ansoff Matrix
  • Fig. 65 Market differentiators
  • Fig. 66 Key company market share analysis, 2022
  • Fig. 67 Company market position analysis
  • Fig. 68 Competitive dashboard analysis
  • Fig. 69 Regional network map